The Research and Development team at XNK Therapeutics is dedicated to advancing autologous NK cell therapies for cancer treatment. Comprised of experts in scientific research, regulatory affairs, and clinical operations, the team collaborates to design and execute innovative studies, ensure regulatory compliance, and streamline the production of therapeutic products, ultimately driving the development of effective cancer therapies.
View all